Detalhe da pesquisa
1.
Safety and performance of the Clearum™ high flux hemodialyzer.
Artif Organs
; 48(4): 365-374, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37962073
2.
Potential life-years gained over a 5-year period by correcting DOPPS-identified modifiable practices in haemodialysis: results from the European MONITOR-CKD5 study.
BMC Nephrol
; 20(1): 81, 2019 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30836953
3.
Long-term treatment with biosimilar epoetin-α (HX575) in hemodialysis patients with renal anemia: real-world effectiveness and safety in the MONITOR-CKD5 studyâ©.
Clin Nephrol
; 89 (2018)(1): 1-9, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29168688
4.
Early low-dose erythropoiesis-stimulating agent therapy and progression of moderate chronic kidney disease: a randomized, placebo-controlled trial.
Nephrol Dial Transplant
; 32(2): 279-287, 2017 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28186540
5.
Simplifying and expanding the screening for peptides <2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometry.
J Sep Sci
; 39(2): 333-41, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26578461
6.
Results from a safety cohort of patients with renal anemia receiving the biosimilar epoetinzeta: The PASCO I study.
Clin Nephrol
; 84(5): 280-8, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26396097
7.
The effects of colestilan versus placebo and sevelamer in patients with CKD 5D and hyperphosphataemia: a 1-year prospective randomized study.
Nephrol Dial Transplant
; 29(5): 1061-73, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24302608
8.
Darbepoetin alfa once monthly corrects anaemia in patients with chronic kidney disease not on dialysis.
Nephrology (Carlton)
; 19(5): 266-74, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24506498
9.
Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Phase 3 Roxadustat Trials in Japan.
Adv Ther
; 41(4): 1526-1552, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38363463
10.
Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Four Global Roxadustat Phase 3 Trials.
Adv Ther
; 41(4): 1553-1575, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38363466
11.
Epoetin alfa biosimilar (HX575): A review of 15 years' post-approval clinical experience.
Crit Rev Oncol Hematol
; 181: 103894, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36481307
12.
Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies.
Adv Ther
; 40(4): 1546-1559, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36749544
13.
Efficacy and safety of lanthanum carbonate in German patients on dialysis.
Clin Nephrol
; 78(5): 382-90, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22948119
14.
Immunogenicity and safety of a booster dose of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) compared with HepB-Eng (Engerix-B®) and HepB-AS04 (Fendrix®) in adults receiving hemodialysis who previously received hepatitis B vaccination and are not seroprotected: Results of a randomized, multicenter phase 3 study.
Hum Vaccin Immunother
; 18(6): 2136912, 2022 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36269938
15.
Detection of follistatin-based inhibitors of the TGF-ß signaling pathways in serum/plasma by means of LC-HRMS/MS and Western blotting.
Drug Test Anal
; 12(11-12): 1636-1648, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32959984
16.
First-in-human Phase I studies of PRS-080#22, a hepcidin antagonist, in healthy volunteers and patients with chronic kidney disease undergoing hemodialysis.
PLoS One
; 14(3): e0212023, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30917125
17.
Sotatercept Safety and Effects on Hemoglobin, Bone, and Vascular Calcification.
Kidney Int Rep
; 4(11): 1585-1597, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31891000
18.
Detection of the Human Anti-ActRII Antibody Bimagrumab in Serum by Means of Affinity Purification, Tryptic Digestion, and LC-HRMS.
Proteomics Clin Appl
; 12(3): e1700120, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29226558
19.
HX575: established biosimilarity in the treatment of renal anemia and 10 years of clinical experience.
Drug Des Devel Ther
; 12: 9-14, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29296077
20.
Epoetin Biosimilars in the Treatment of Renal Anemia: What Have We Learned from a Decade of European Experience?
Clin Drug Investig
; 38(6): 481-490, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29500617